Management of chronic rhinosinusitis with steroid nasal irrigations: A viable nonsurgical alternative in the COVID-19 era

Int Forum Allergy Rhinol. 2020 Sep;10(9):1108-1109. doi: 10.1002/alr.22646. Epub 2020 Jul 16.

Authors

Auddie M Sweis¹, Tran B Locke¹, Jennifer E Douglas¹, Theodore C Lin^{1

2}, Brian M Sweis³, Alyssa M Civantos¹, David W Kennedy¹

Affiliations

¹ Department of Otorhinolaryngology, University of Pennsylvania, Philadelphia, PA.
² Lewis Katz School of Medicine, Temple University, Philadelphia, PA.
³ Department of Neuroscience, University of Minnesota, Minneapolis, MN.

No abstract available

Publication types

Letter

MeSH terms

Adult
Aged
Anti-Inflammatory Agents / administration & dosage*
Anti-Inflammatory Agents / therapeutic use
Betacoronavirus*
Budesonide / administration & dosage
Budesonide / therapeutic use
COVID-19
Chronic Disease
Coronavirus Infections / prevention & control*
Drug Administration Schedule
Female
Humans
Male
Middle Aged
Mometasone Furoate / administration & dosage
Mometasone Furoate / therapeutic use
Nasal Lavage / methods*
Pandemics / prevention & control*
Pilot Projects
Pneumonia, Viral / prevention & control*
Pregnanes / administration & dosage*
Pregnanes / therapeutic use
Retrospective Studies
Rhinitis / drug therapy*
SARS-CoV-2
Sinusitis / drug therapy*
Treatment Outcome

Substances

Anti-Inflammatory Agents
Pregnanes
Mometasone Furoate
Budesonide